Your browser doesn't support javascript.
loading
Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial.
Parker, Catriona; Krishnan, Shekhar; Hamadeh, Lina; Irving, Julie A E; Kuiper, Roland P; Révész, Tamas; Hoogerbrugge, Peter; Hancock, Jeremy; Sutton, Rosemary; Moorman, Anthony V; Saha, Vaskar.
Afiliación
  • Parker C; Childrens Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Krishnan S; Childrens Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, New Town, Kolkata, India.
  • Hamadeh L; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Irving JAE; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Révész T; Department of Haematology-Oncology, SA Pathology at Women's and Children's Hospital, and University of Adelaide, Adelaide, SA, Australia.
  • Hoogerbrugge P; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Dutch Childhood Oncology Group, Utrecht, Netherlands.
  • Hancock J; Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
  • Sutton R; Children's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.
  • Moorman AV; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
  • Saha V; Childrens Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, New Town, Kolkata, India. Electronic address: v.saha@manchester.ac.uk.
Lancet Haematol ; 6(4): e204-e216, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30826273
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Haematol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médula Ósea / Leucemia-Linfoma Linfoblástico de Células Precursoras B Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Haematol Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido